December 1, 2009
GenomeWeb Daily News - Bioo Therapeutics, Texas Tech Research Collaborate on siRNA Delivery to T Cells
Bioo Therapeutics, a division of Bioo Scientific, said this month that it has signed a collaborative research agreement with Texas Tech University researcher Premlata Shankar to develop methods to deliver siRNAs into T cells.
Under the deal, Shankar will use Bioo’s Targeted Transport Technology, which involves joining a carrier agent to a monoclonal antibody to produce a conjugate that is then loaded with an RNAi molecule such as an siRNA or miRNA mimic, to deliver anti-HIV siRNAs into T cells.
This article also appeared in the following outlet(s)
- AIDS Weekly
- Biotech Week
- Immunotherapy Weekly
- NewsRx.com
- Pharma Business Week
Print
+ Font
- Font